IART Q1 2020 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

Q1 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$354M-1.5% YoY

Gross Profit

$221M62.3% margin

Operating Income

$27M7.6% margin

Net Income

$9M2.6% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

-10.3%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

-$705,000

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$2.1B

Stockholders' Equity

$1.3B

Cash & Equivalents

$358M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$354M	$360M	-1.5%
Gross Profit	$221M	$231M	-4.3%
Operating Income	$27M	$32M	-16.1%
Net Income	$9M	$33M	-72.0%

Revenue Segments

Codman Specialty Surgical

$231M65%

Orthopedics and Tissue Technologies

$123M35%

Geographic Segments

UNITED STATES

$247M70%

Europe

$46M13%

Asia Pacific

$40M11%

Rest Of World

$22M6%